ALBERTDAVDNSEAlbert David LimitedMinimalNeutral
Announced Wed, 13 May · 13:11 IST

Albert David Limited has informed the Exchange about Copy of Newspaper Publication

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-10.5%1-day move
₹790.00
prior close
₹716.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.4-10.5-8.6-10.1-9.2-10.4-10.6-8.8-8.3-11.2
Up moveDown movePending
AI summary

Albert David Limited, a Kothari Group pharmaceutical manufacturer, has published its audited financial results for the quarter and year ended March 31, 2026 in Financial Express and Aajkaal newspapers. Total income from operations declined to Rs. 33,359.81 Lakhs from Rs. 34,576.80 Lakhs in the previous year. Net profit after tax dropped significantly to Rs. 52.49 Lakhs from Rs. 252.77 Lakhs. Annualised EPS fell to Rs. 2.82 from Rs. 30.14 in the prior year. Despite lower profitability, the company's net worth improved slightly to Rs. 2,700.98 Lakhs (from Rs. 2,590.88 Lakhs). The Board has recommended a dividend of Rs. 5 per equity share (face value Rs. 10). Statutory auditors issued an unmodified opinion, and results were approved by the Board on May 12, 2026. The company operates in a single reportable segment - pharmaceuticals.

Likely market impact

The sharp decline in net profit and EPS despite marginal revenue drop indicates potential margin compression or operational challenges. Shareholders may see pressure on returns, though the dividend recommendation shows management's intent to maintain shareholder payouts.